Events & Webinars

This year at ASCO we will feature advances in our leading Predictive + Generative AI Platform, AI SaaS Solutions for Accelerated Oncology Trials, Life Sciences and Healthcare Ecosystem, and the Largest Oncology RWD Dataset; just to name a few. Click here to set up a meeting in advance or visit our booth #12045. Looking forward to seeing you there!

As a leader in healthcare technology, we recognize the importance of staying up-to-date with the latest developments in classical and malignant hematology. The ASH Annual Meeting and Exposition is the premier event for hematology experts from around the world, and we are thrilled to be part of this comprehensive event.

We can’t wait to join the world’s leading hematology experts at the 65th ASH Annual Meeting and Exposition in San Diego. Mark your calendars now and we hope to see you there!

As a healthcare industry representative, you won’t want to miss the opportunity to connect with ConcertAI at this event. ESMO 2023 will provide unparalleled networking opportunities for attendees from all around the world. Engage with our leading experts, stay up-to-date on emerging trends in oncology research, and build new partnerships that will drive innovation in your organization.

If you’re looking to expand your knowledge and make a real impact in the fight against cancer, meet with us at ESMO 2023. We’ll see you in Madrid!

ConcertAI is excited to share that we will be attending the BioTechX EU event from October 4-6, 2023, in Basel, Switzerland. Recognized as Europe’s premier event for pharmaceutical development and healthcare, BioTechX EU emphasizes Data, AI, Precision, and Innovation for the pharmaceutical, healthcare, and partner industries.

Our eagerness to participate stems from a few key areas of interest:

1. Sharing our extensive collection of U.S. Oncology Real World Data (RWD)
2. Highlighting the transformational impact of our AI-driven RWD solutions
3. Showcasing the breadth of ConcertAI applications across the drug development lifecycle
4. Discussing innovations in data, services, and technology

Explore our 2023 ASCO Session with Warren Whyte (ConcertAI) and Nick Kenny (Syneos Health) discussing AI’s role in reducing health disparities, ethical use, and regulation for equitable healthcare.

Join ConcertAI at ISPOR 2023, the premier global conference for health economics and outcomes research (HEOR) from May 7-10. This essential event brings together healthcare leaders to share the latest trends in healthcare and explore innovative ways to create sustainable value for health systems, patients, and technology developers. As a leading healthcare technology company, ConcertAI’s presence at ISPOR 2023 is essential. Don’t miss out on unparalleled networking opportunities and the chance to share your thoughts and ideas with a global audience. Set up a meeting now to take the first step towards transforming the healthcare industry!

How do we accelerate trial diversity towards ensuring proper representation, particularly where traditional approaches prove insufficient? At SCOPE 2023 ConcertAI’s Warren Whyte, PhD (VP of RWE Sciences and ERACE Lead) presented a meaningful trial diversity and engagement strategy using real-world data and AI-enabled technologies. Learn how to foster engagement, encourage enrollment, and measure differences in cancer care across regions and population groups.

Join us in New Orleans, Louisiana, December 10-13, 2022, for the premier event in malignant and classical hematology.  Discuss how our solutions meet your needs at all phases of your product lifecycle.

ConcertAI is heading to SABCS 2023, a global symposium that’s at the forefront of breast cancer research and care. We look forward to immersing ourselves in expert lectures, presentations, and discussions on cutting-edge cancer science. Joining 9,500 attendees from over 100 countries, we’re ready to drive the future of healthcare with our AI-powered insights.

Let’s connect in advance to make the most of this unique event. Together, we can advance cancer care.

TeraRecon will be exhibiting at RSNA23 in Chicago, Illinois. Schedule a meeting with us!

Experience the future of pharma and healthcare at BioTechX Europe 2024 with ConcertAI. Let’s innovate and lead together!

Join us Oct 1-3 in Washington DC at the AACI/CCAF Annual Meeting. As the largest translational and clinical development platform, ConcertAI is set to:

• Accelerate patient identification.
• Ease trial burdens for staff.
• Boost trial participant diversity.

Dive into the future of precision oncology with us through AI-driven trials and clinico-genomics data. See you in DC for this groundbreaking collaboration!

Meet us at ESMO Congress 2024 to explore the latest in oncology research and AI-driven patient care with ConcertAI

Meet ConcertAI in Paris and network with your colleagues, interact with key opinion leaders, ask questions and debate on burning topics in the field of medical oncology. You will have the chance to learn firsthand, about practice challenges and controversies, brainstorm with peers and explore further opportunities to advance your career.

ConcertAI is thrilled to announce our participation in BioTechX USA on September 6-7, 2023 at the Santa Clara Convention Centre in sunny California. As America’s premier biotechnology congress, BioTechX plays a pivotal role in bridging the worlds of pharma, academia, and clinicians.

We are especially keen to engage in discussions on:

• Having the industry’s most expansive U.S. Oncology Real World Data (RWD)
• How our AI-driven RWD solutions are revolutionizing the analysis & utilization of data
• ConcertAI applications spanning the entire drug development lifecycle
• Innovations in data, services, and technology

Digital innovation is transforming the world of drug development and better equipping pharmaceutical companies than ever before to deliver the right treatments to the right patients, at the right time. Nonetheless, as these technologies evolve, there is still much to learn.

In this forward-thinking panel event, Fast Company and Bristol Myers Squibb’s thought leaders and top executives are convening to share their insights on the extraordinary opportunities that lie ahead.

We’re excited to be attending ICPE 2023: The Global Home for the Science of Real-World Evidence this year in Halifax, Nova Scotia, Canada. The conference provides an international platform for the latest advancements and discussions on real-world data and its significant impacts on healthcare. Meet with one of ConcertAI’s team members to learn how our AI-driven real-world data solutions transform the way health data is analyzed and utilized. With our innovative AI solutions, ConcertAI is at the forefront of revolutionizing health and life sciences, bringing a new perspective to ICPE 2023.

As a leader in Real-World Evidence (RWE) and AI technology solutions for life sciences and healthcare, our mission is to accelerate insights and outcomes for patients through leading real-world data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies. We are currently partnering with QCCA to progress cancer research through RWD and imaging studies as well as streamline the clinical trial process through our Digital Trial Solution technology that integrates directly into the clinical workflow. Meet with us at this year’s QCCA Fall Leadership Summit.

Join the dialogue on health economics and outcomes at ISPOR 2024 with ConcertAI. Let’s innovate for better healthcare solutions.

ConcertAI is thrilled to attend Asembia’s 2023 Specialty Pharmacy Summit! This event is a crucial gathering of key players in the pharmacy industry, and we can’t wait to be part of the conversation. As a leading healthcare technology company, we’re committed to staying at the forefront of innovation in the specialty pharmacy space. The Summit provides a unique opportunity for us to network, attend informative sessions, and explore exhibits with industry experts from all corners of the healthcare industry. At ConcertAI, we know that collaboration is key to defining the future of healthcare. We’re excited to connect with stakeholders from throughout the industry to share our insights, generate solutions, and advance the cause of improving patient outcomes. We hope to see you there!

Connect with ConcertAI at Asembia’s AXS24 Summit to shape the future of specialty pharmacy. Let’s accelerate healthcare together!

Our panel of key opinion leaders in clinical research from both sponsor and provider side will discuss the innovation happening in clinical trial design, recruitment, and execution. We will talk about the challenges facing sites impacting day-to-day care and clinical research. Panelists will discuss innovative approaches to traditional ways of running clinical trials.

Learn more about our new class of real world datasets in our clinical molecular RWD comprised of researched great EMR combined with whole exome sequencing, transcriptomics and IEC. We’re going to have a lot of great opportunities and discussions to support life science innovators bringing new therapeutics into the clinic.

Join ConcertAI at the AACR Annual Meeting to explore revolutionary cancer research and AI-augmented care solitions. Discover how we’re transforming patient outcomes with Gen AI.

TeraRecon will be exhibiting at ECR23 in Vienna, Austria. Schedule a meeting with us!

Join ConcertAI at SCOPE 2024 for insightful discussions on clinical trial advancements. Discover how AI is transforming clinical research.

We’re excited to attend SCOPE Summit February 6-9, 2023 in Orlando, FL at Rosen Shingle Creek. This year at SCOPE, meet with one of our many attending team members to learn how ConcertAI is using real world data to accelerate oncology clinical trials. Set up a meeting in advance or swing by booth #222 for a live demo.

Discover the future of healthcare with ConcertAI at the JP Morgan Healthcare Conference 2024. Join us in San Francisco for pivotal discussions on AI-driven healthcare advancements.

This discussion captured at SCOPE 2024 focuses on the collaboration between Exigent Research and ConcertAI in enhancing clinical trials. This collaboration introduced the just-in-time model to overcome recruitment challenges, such as low enrollment and delays, by emphasizing quick patient identification and site activation for specific populations.

Explore the transformation and future of oncology as esteemed guest George Sledge, PhD (Caris Life Sciences, CMO) and Jeff Elton, PhD (ConcertAI, CEO) discuss diverse data strategies and showcase the future of precision medicine underpinning our partnership.

Explore how to eliminate racial disparities and broaden clinical trial patient equity in a webinar with leaders in pharma, academia and digital technology. Panelists discuss challenges including access and barriers, reporting, and best areas to accelerate toward achieving equitable outcomes.

This webinar takes an epidemiological approach to using real-world data and AI optimization and prediction technologies to rapidly analyze patient clinical and demographic characteristics, biomarkers, treatment and outcomes – to aid the further investigation of health disparities.

Learn how advanced RWD and AI technologies are helping find more patients from diverse racial backgrounds who are eligible to enroll in oncology trials.

Oncology clinical trial complexity contributes to high site and patient burden and nearly 30% of patients dropping out before study completion. Clinical trials must become more patient-centric, and the COVID-19 pandemic has only further underscored the need to do so.

This mini webinar focuses on using real-world data and AI technologies drawn directly from clinical and site data to rapidly iterate during the study design process – for studies that result in more successful patient enrollment rates.

Explore how innovative and advanced data and AI technologies can deliver rapid real-world insights unto treatments and outcomes to inform patient cohort sizes and statistical power considerations and positively affect potential recruitment.

As hematological studies are restarted, modified, and redesigned, the need for innovative technologies and rapid study redesign has become critical. Watch how data, and AI optimization and prediction can lead to more robust, efficient, and lower risk clinical studies.

View an example of how advanced real-world data, sponsor data, and AI optimization and prediction can lead to more robust, efficient, and lower risk clinical studies, with a focus on solid tumor trials.

Watch as two expert scientists from ConcertAI discuss how novel study designs like External Control Arms (ECAs) are meeting the moment with custom, regulatory-grade data abstraction and advanced technologies.

Learn how “living” datasets work and how such advanced oncology RWD can accelerate an enterprise-level approach to RWE.

Join experts from ViiV Healthcare, Click Therapeutics, ConcertAI and Data Unveil as they discuss how to move the needle on patient adherence and redefine market expectations by implementing advanced analytical models such as machine learning and Artificial Intelligence to facilitate improved patient outcomes.

Leaders from pharmaceutical, academia, and digital technology discuss how to eliminate racial disparities and broaden access for patient equity. Explore the challenges to addressing inequities in cancer care; access and barriers, reporting, and best areas to accelerate toward achieving equitable outcomes.